Back

Life Sciences

Chambers Europe

“Profound knowledge, excellent support and good customer service skills.”

Legal 500

“Very good, specialized lawyers, the team collaborates efficiently together to meet with their clients’ needs in a timely manner; Projects are well managed and prioritized.”

Who's Who Legal Switzerland Life Sciences

“Well known for work in the life sciences space” / “Advice has always been timely and of the highest quality.”

The World’s Leading Patent Professionals

“A courtroom favourite among major life sciences players.”

Legal 500

“The company is outstanding at analysing contracts and identifying risks and best solutions for the counterparty. It is committed to finding the best solutions tailored to the client’s needs.”

         

Practice Group

Schellenberg Wittmer’s Life Sciences Group is a leading practice for dispute resolution, transactional work and regulatory matters in the field of life sciences. We advise and represent companies from a variety of sectors, including pharma, biotechnology, medical devices, cosmetics, and food and beverages.

Expertise

Experience

Schellenberg Wittmer’s Life Sciences Group has broad expertise in representing life sciences clients in complex international disputes and in advising on corporate and commercial matters, such as complex licensing deals, joint ventures and M&A transactions.

Additionally, we provide guidance in regulatory matters and advise on data protection, compliance and investigations, e-health, software and competition law.

Litigation/Arbitration

We represent clients in litigation, arbitration and mediation proceedings over a broad range of issues, including:

  • Entitlement, validity and infringement of patents, SPCs and other IP right
  • Disputes arising from licensing, distribution, non-disclosure, R&D, technology transfer, manufacturing and clinical trials agreements
  • Product liability and product recall matters

Corporate and Commercial

  • R&D, licensing and development, IP acquisitions, manufacturing, distribution and option agreements
  • Joint ventures
  • M&A transactions
  • Venture capital and private equity

 

Advice and Regulatory

  • Clinical trials
  • Pharmaceutical advertising
  • Interactions with HCP
  • Compliance and investigations
  • Data protection, e-health and medical software
  • Competition law
  • Representation of a US pharmaceutical company in a USD 210 million arbitration against a German pharmaceutical company concerning non-compliance with GMP, supply of deficient drug product and product recalls
  • Counsel to Santhera Pharmaceuticals on various complex, multi-jurisdictional licensing and asset sale deals
  • Counsel to Shire in the closing in Switzerland of the global sale of its oncology business to Servier SAS
  • Counsel to PM Equity Partner LLC, the corporate venture fund of Philip Morris International, in its acquisition of a minority shareholding in Biovotion AG
  • Swiss counsel to Cardinal Health, a leading manufacturer of medical and surgical products, in its acquisition of Medtronic’s Patient Recovery business for USD 6.1 billion
  • Representation of various pharmaceutical companies in notification procedures following data breaches
  • Swiss counsel to Panasonic Healthcare in its acquisition of the Diabetes Care business from Bayer (total transaction value approx. EUR 1 billion)
  • Representation of a medical device company in the Swiss part of global product liability litigation
  • Representation of a major cosmetics retailer before regulatory authorities and in several product recall cases
  • Swiss counsel to Cardinal Health in the acquisition of Johnson & Johnson’s Cordis business, a global leader in cardiology and endovascular devices
  • Representation of a major Swiss medical device manufacturer in patent litigation before the Swiss Federal Patent Court
  • Representation of a Swiss pharma and biotech company in an investigation by the Swiss competition authority over an alleged abuse of a dominant position based on licensing agreements
  • Comprehensive data protection advice to a global manufacturer of skincare products
  • Data protection and health regulatory advice to a provider of health checks offered to employees of customers

Contact

Partners

Full Team

Stéphanie Chuffart-Finsterwald

Dr. Stéphanie Chuffart-Finsterwald

Partner

Geneva +41 22 707 8000

Show more VCard

 

Lorenza Ferrari Hofer

Dr. Lorenza Ferrari Hofer

Partner

Zurich +41 44 215 3600

Show more VCard

 

Philipp Groz

Philipp Groz

Partner

Zurich +41 44 215 9379

Show more VCard

 

Stéphanie Chuffart-Finsterwald

Dr. Stéphanie Chuffart-Finsterwald

Partner

Geneva +41 22 707 8000

Show more VCard

 

Lorenza Ferrari Hofer

Dr. Lorenza Ferrari Hofer

Partner

Zurich +41 44 215 3600

Show more VCard

 

Philipp Groz

Philipp Groz

Partner

Zurich +41 44 215 9379

Show more VCard

 

Pascal Hubli

Pascal Hubli

Partner

Zurich +41 44 215 9380

Show more VCard

 

Marcel Jakob

Marcel Jakob

Partner

Zurich +41 44 215 3447

Show more VCard

 

David Mamane

David Mamane

Partner

Zurich +41 44 215 3420

Show more VCard

 

Roland Mathys

Roland Mathys

Partner

Zurich +41 44 215 3662

Show more VCard

 

Oliver Triebold

Dr. Oliver Triebold

Partner

Zurich +41 44 215 5269

Show more VCard

 

Christoph Vonlanthen

Christoph Vonlanthen

Partner

Geneva / Zurich +41 22 707 8177

Show more VCard

 

Manon Baur

Manon Baur

Associate

Geneva +41 22 707 81 42

Show more VCard

 

Frank Bremer

Dr. Frank Bremer

Counsel

Zurich +41 44 215 9378

Show more VCard

 

Stéphanie Chuffart-Finsterwald

Dr. Stéphanie Chuffart-Finsterwald

Partner

Geneva +41 22 707 8000

Show more VCard

 

Lorenza Ferrari Hofer

Dr. Lorenza Ferrari Hofer

Partner

Zurich +41 44 215 3600

Show more VCard

 

Alain Grieder

Dr. Alain Grieder

Senior Associate

Singapore +65 6580 2246

Show more VCard

 

Philipp Groz

Philipp Groz

Partner

Zurich +41 44 215 9379

Show more VCard

 

Patrick Gürtler

Patrick Gürtler

Associate

Zurich +41 44 215 3621

Show more VCard

 

Adrienne Hennemann

Adrienne Hennemann

Senior Associate

Zurich +41 44 215 3665

Show more VCard

 

Pascal Hubli

Pascal Hubli

Partner

Zurich +41 44 215 9380

Show more VCard

 

Marcel Jakob

Marcel Jakob

Partner

Zurich +41 44 215 3447

Show more VCard

 

Linda Kubli

Dr. Linda Kubli

Associate

Zurich +41 44 215 3627

Show more VCard

 

Greg Lourie

Dr. Greg Lourie

Counsel

Zurich +41 44 215 3494

Show more VCard

 

David Mamane

David Mamane

Partner

Zurich +41 44 215 3420

Show more VCard

 

Roland Mathys

Roland Mathys

Partner

Zurich +41 44 215 3662

Show more VCard

 

Peter Georg Picht

Prof. Dr. Peter Georg Picht

Of Counsel

Zurich +41 44 215 5254

Show more VCard

 

Serafin Ritscher

Serafin Ritscher

Associate

Zurich +41 44 215 5281

Show more VCard

 

Annapoorni Sitaraman

Annapoorni Sitaraman

Associate

Geneva +41 22 707 80 73

Show more VCard

 

Oliver Triebold

Dr. Oliver Triebold

Partner

Zurich +41 44 215 5269

Show more VCard

 

Christoph Vonlanthen

Christoph Vonlanthen

Partner

Geneva / Zurich +41 22 707 8177

Show more VCard

 

Alisa Zehner

Alisa Zehner

Associate

Zurich +41 44 215 5213

Show more VCard

 

Noémi Ziegler

Noémi Ziegler

Senior Associate

Zurich +41 44 215 5288

Show more VCard

 

Highlights

Lorenza Ferrari Hofer elected president of AIPPI International

22.10.2024

Schellenberg Wittmer is proud to announce that our partner Lorenza Ferrari Hofer was elected president of AIPPI International.

Show more

 

Schellenberg Wittmer welcomes three new Partners and one Counsel to the firm

27.09.2024

Schellenberg Wittmer is pleased to announce the addition of three new Partners and one Counsel to our team.

Show more

 

Schellenberg Wittmer advised Boehringer Ingelheim on its acquisition of Saiba Animal Health

05.09.2024

Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Saiba Animal Health AG.

Show more

 

Insights

Show all  

Deals & Cases

Schellenberg Wittmer advises Dr. Reddy's Laboratories on acquisition of Haleon plc's consumer healthcare NRT business

30.09.2024

Show more

 

Deals & Cases

Schellenberg Wittmer advised Boehringer Ingelheim on its acquisition of Saiba Animal Health

05.09.2024

Show more

 

Deals & Cases

Schellenberg Wittmer advised Bioventure on Series C Financing Round of the Swiss Aphaia Companies

21.12.2023

Show more

 

Deals & Cases

Schellenberg Wittmer advises Gilde Healthcare on investment in Swiss Dental Solutions

20.12.2023

Show more

 

Deals & Cases

Schellenberg Wittmer advised Santhera on the sale of its Raxone®/Idebenone business

31.07.2023

Show more

 

Deals & Cases

Schellenberg Wittmer acted as co-counsel for Sosei Heptares

20.07.2023

Show more

 

Deals & Cases

Schellenberg Wittmer advises Santhera on license for North America for Vamorolone

20.06.2023

Show more

 

Deals & Cases

Schellenberg Wittmer advised Bioventure on Series B Financing Round of the Swiss Aphaia Companies

06.09.2022

Show more

 

Deals & Cases

Perfect Holding completes Reverse Takeover Transaction with Kinarus

03.06.2022

Show more

 

Deals & Cases

Schellenberg Wittmer advises Kinarus in Transaction Agreement with Perfect Holding

31.03.2022

Show more

 

Deals & Cases

Schellenberg Wittmer advised Santhera on exclusive license agreement for Vamorolone

04.01.2022

Show more

 

Deals & Cases

Schellenberg Wittmer advises AOP Orphan Pharmaceuticals on its license agreement with Eagle Pharmaceuticals

09.08.2021

Show more

 

Deals & Cases

Schellenberg Wittmer Advises AddLife on the acquisition of Vision Ophthalmology Group

08.04.2021

Show more

 

Deals & Cases

Santhera Enters into Option and Sublicense Agreement with Idorsia

22.11.2018

Show more

 

Deals & Cases

Schellenberg Wittmer advises Santhera Pharmaceuticals in exclusive License Agreement with Polyphor

15.02.2018

Show more

 

Deals & Cases

Schellenberg Wittmer advises Cardinal Health in acquisition of Medtronic division

30.07.2017

Show more

 

Awards & Recognitions

The group and leading practitioners are well recognised among leading law firms across international directories and publications:

  • Chambers Europe in Life Sciences
  • Legal 500 in Life Sciences
  • Lexology Index in Life Sciences
  • The World’s Leading Patent Professionals
  • The World’s Leading Trademark Professionals
  • Managing Intellectual Property IP Stars
Show all  

Books & Articles

  "Commercially Reasonable Efforts” in Life Sciences Agreements   Licensing in Life Sciences: New developments   Der "Sorafenibtosylat"-Entscheid – Neues zum Massnahmenverfahren vor dem Bundespatentgericht / Kommentierung des Entscheides des Bundespatentgerichts vom 26. April 2022
Show all  

Download Factsheet

  Download PDF
 

Stay up to date!

*Required fields

Newsletters & Newsflashes

Monthly selected key topics from our practice areas, sectors and industries, plus newsflashes on recent developments.

Publications

Monthly email with the latest updates and summaries of the Swiss Federal Supreme Court's case law in arbitration matters.
Regular insights into Swiss and international trends and legal developments in the construction industry.
Regular insights and updates on key developments in the rapidly changing landscape of Environmental, Social and Corporate Governance disputes.
Concise analysis of key trends in the fast-moving world of corporate governance for board members of Swiss companies.
A regular look from a unique M&A perspective at legal changes, economic developments and societal trends in Switzerland.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.